Lipid refers to fat comprising proteins and carbohydrates. Cholesterol and triglycerides are lipids that are stored in the human body and serve as a source of energy. Dyslipidaemia is the imbalance in the lipid level in the bloodstream. It is characterized by high levels of total cholesterol and low-density lipoprotein cholesterol (LDL-C) in the blood. High cholesterol levels can cause cardiovascular diseases (CVD) such as stroke and atherosclerosis. The typical range of total blood cholesterol is 140-200 mg/dL. Blood cholesterol contains individual components such as LDL-C and high-density lipoprotein cholesterol (HDL-C). Low-density lipoprotein (LDL) carries cholesterol to the body while high-density lipoprotein (HDL) removes cholesterol from the cells by reversing cholesterol transport to the liver. Due to their distinct roles, these components are individually assessed to determine the dyslipidemic status of an individual.

Technavio’s analysts forecast the global dyslipidemia drugs market to grow at a CAGR of 5.27% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global dyslipidemia drugs market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Dyslipidemia Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

細菌性膣病治療薬の世界市場2017-2021：経口薬、局所薬 IRTNTR14695 / Technavio / 2017年9月12日 / Technavio社が発行した当調査レポートでは、細菌性膣病治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、細菌性膣病治療薬の世界市場規模及び予測、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。Technavio社は細菌性膣病治療薬の世界市場が2017-2021年期間中に年平均2.16%成長すると予測しています。当レポート上に記載されている主な企業はBayer、Pfizer、Sanofi、Starpharma Holdings等です。...About Bacterial Vaginosis Drugs BV is a vaginal disease caused due to complex alteration of flora present in the vagina. Antibacterial drugs are used for the treatment of BV, some of the most common drugs used for the treatment of the disease include Metronidazole, Clindamycin, and Tinidazole. The drugs are used in both oral and topical forms. Two types of bacteria are found in the genital parts of the women, termed as good bacteria and bad bacteria. The good bacteria present in the vagina are lactobacilli, which prevents the growth of bad bacteria. Technavio’s analysts forecast the global bacterial vaginosis...

狭心症治療薬の世界市場2017-2021：β遮断薬、カルシウムチャネル遮断薬、硝酸薬、アンジオテンシン変換酵素阻害薬、その他 IRTNTR14638 / Technavio / 2017年8月24日 / Technavio社が発行した当調査レポートでは、狭心症治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、狭心症治療薬の世界市場規模及び予測、薬剤種類別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。Technavio社は狭心症治療薬の世界市場が2017-2021年期間中に年平均4.05%成長すると予測しています。当レポート上に記載されている主な企業はAstraZeneca、Gilead、Novartis、Pfizer等です。...About Angina Pectoris Drugs Angina is a type of chest pain or discomfort caused due to a coronary heart disease, specifically due to reduced blood flow to the heart. For angina pectoris drugs market, beta blockers remain the most preferred line of treatment. However, the treatment market witnesses a strong presence of other drug classes such as calcium channel blockers. Though the market is fragmented, large players such as AstraZeneca, Gilead, Novartis, and Pfizer hold significant positions. Technavio’s analysts forecast the global angina pectoris drugs market to grow at a CAGR of 4.05% during the period 2017-2021. [Covered in this...

制吐薬の世界市場2017-2021 IRTNTR13557 / Technavio / 2017年6月14日 / 当調査レポートでは、制吐薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、制吐薬の世界市場規模及び予測、用途別分析、薬剤種類別分析、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Antiemetic DrugEmesis is defined as forceful expulsion of stomach content either due to humoral stimulation due to chemoreceptor trigger zone (CRTZ) or neural stimulation of emetic centers. The various drugs that are used to treat this condition of emesis are known as antiemetics. The various classes of drug available for management of emesis are serotonin antagonist, dopamine antagonist, NK1 receptor antagonist, antihistaminic, steroids, and anticholinergic. The various applications of antiemetic drugs include chemotherapy, surgery, gastroenteritis, morning sickness, motion sickness, stress-induced emesis, and drugs-induced emesis. This market is primarily volume driven as majority of drugs are available in generic form....

抗精神病薬の世界市場2017-2021 IRTNTR12354 / Technavio / 2017年6月7日 / 当調査レポートでは、抗精神病薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、抗精神病薬の世界市場規模及び予測、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Antipsychotic Drugs Antipsychotic drugs are also called as major tranquilizers or neuroleptics. These drugs are primarily used for the treatment of psychiatric disorders such as schizophrenia, hallucinations, delusions, bipolar disorder, and others. The antipsychotic drugs market is expected to grow due to the rising number of schizophrenic patients. Technavio’s analysts forecast the global antipsychotic drugs market to grow at a CAGR of 1.84% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global antipsychotic drugs market for 2017-2021. To calculate the market size, the report considers sales from...

前立腺肥大症（BPH）治療薬の世界市場2017-2021 IRTNTR13127 / Technavio / 2017年5月10日 / 当調査レポートでは、前立腺肥大症（BPH）治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、前立腺肥大症（BPH）治療薬の世界市場規模及び予測、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...ABSTRACTAbout Benign Prostatic Hyperplasia Drugs Urology is a branch of medicine that deals with the health of the urinary tract and reproductive tract in men and women. Urologic diseases or conditions include infection in the urinary tract, bladder control problems, kidney stones and prostate problems, among others. The prostate gland surrounds the urethra, the tube that carries urine from the bladder out of the body. Benign prostatic hyperplasia (BPH) is an enlarged prostate, which increases the size of the prostate gland. As the prostate gets enlarged, it may squeeze or partly block the urethra, resulting in significantly blocking urine flow....

アレルギー性鼻炎（AR）治療薬の世界市場2017-2021 IRTNTR13154 / Technavio / 2017年5月10日 / 当調査レポートでは、アレルギー性鼻炎（AR）治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、アレルギー性鼻炎（AR）治療薬の世界市場規模及び予測、薬剤種類別分析、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況などの情報をお届けいたします。...ABSTRACTAbout Allergy Rhinitis Drugs Allergic rhinitis refers to the inflammation of nasal membranes that causes nasal congestion, sneezing, itching, and rhinorrhea. This condition is usually caused by dust, animal dander, pollen, and certain food ingredients. Allergic rhinitis or hay fever occurs when the immune system overreacts to allergens in the air such as dust, animal dander, or pollen. Symptoms can also occur due to various food allergies. Technavio’s analysts forecast the global allergy rhinitis drugs market to grow at a CAGR of 3.05% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth...

肥大型心筋症（HCM）治療薬の世界市場2017-2021 IRTNTR12425 / Technavio / 2017年4月5日 / 当調査レポートでは、肥大型心筋症（HCM）治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、肥大型心筋症（HCM）治療薬の世界市場規模及び予測、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...ABSTRACTAbout Hypertrophic Cardiomyopathy Therapeutics HCM is the enlargement of the heart muscle (myocardium), which disrupts the functions of the heart. HCM is mostly caused due to gene mutation and is a significant cause of sudden cardiac death in any age group. Hypertrophy is defined as an enlargement of a tissue or organ, and cardiomyopathy refers to diseases related to heart muscles. Therefore, HCM is defined as a condition, which is characterized by abnormal thickening of heart muscles, which makes pumping of blood from the heart to various organs difficult. Therefore, the heart must induce more pressure to pump blood to...

筋弛緩薬の世界市場2017-2021 IRTNTR12170 / Technavio / 2017年3月7日 / 当調査レポートでは、筋弛緩薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、筋弛緩薬の世界市場規模及び予測、製品別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...ABSTRACTAbout Muscle Relaxant Drugs Muscle spasticity is caused by damage to the spinal cord or brain. Nerves in the brain and spinal cord help relax the muscles during the idle state. Conditions that affect the brain or spinal cord such as multiple sclerosis, cerebral palsy, and stroke can interfere with normal muscle relaxation, leading to involuntary muscle spasms. This will impair the ability to walk, work, sleep, or just function normally. The muscles can also become excessively tense and develop overactive or overresponsive reflexes. Severe cases can lead to deep disability, including an inability to straighten out joints. Technavio’s analysts...

結核治療薬の世界市場2017-2021 IRTNTR11381 / Technavio / 2017年2月10日 / 当調査レポートでは、結核治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、結核治療薬の世界市場規模及び予測、薬剤種類別分析、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Tuberculosis DrugTuberculosis (TB) is caused by Mycobacterium tuberculosis and often affects the lungs. It spreads from person to person through the air in the form of a cough, sneeze or spit. TB affects adults more when compared with children. Technavio’s analysts forecast the global tuberculosis drug market to grow at a CAGR of 3.17% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global tuberculosis drug market for 2017-2021. To calculate the market size, the report considers the volume and services. The market is divided into the following...

抗真菌薬の世界市場2017-2021 IRTNTR11145 / Technavio / 2017年2月10日 / 当調査レポートでは、抗真菌薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、抗真菌薬の世界市場規模及び予測、種類別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Antifungal DrugsAntifungal drugs are chemical compounds used to kill or inhibit the growth of fungi. These drugs act by various mechanisms such as the inhibition of cell division, the inhibition of cell wall formation, and cell membrane disruption. Technavio’s analysts forecast the global antifungal drugs market to grow at a CAGR of 3.20% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global antifungal drugs market for 2017-2021. To calculate the market size, the report considers revenue generated from the sales of branded, generics and OTC drugs used...